The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas

Immune checkpoint blockade, an immunotherapy, has been applied in multiple systemic malignancies and has improved overall survival to a relatively great extent; whether it can be applied in breast cancer remains unknown. We endeavored to explore possible factors that may influence immunotherapy outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kai, Ma, Lei, Sun, Ye, Li, Xiang, Ren, Hong, Tang, Shou-Ching, Sun, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452722/
https://www.ncbi.nlm.nih.gov/pubmed/34545132
http://dx.doi.org/10.1038/s41598-021-98131-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452722/
https://www.ncbi.nlm.nih.gov/pubmed/34545132
http://dx.doi.org/10.1038/s41598-021-98131-4

Ejemplares similares